News | TCTAP 2021 Virtual

The Future of PCI: Indication, Technology, Outlook

Percutaneous coronary intervention (PCI) has gained incredible traction over the years - and leading cardiologists during a special keynote lecture at TCTAP 2021 Virtual on April 21 expounded in detail the direction of its promising future.

April 22, 2021 23262 0 Read More

News | TCTAP 2021 Virtual

Atherosclerotic Plaque Progression and Imaging

The 11th winner of TCTAP award “Master of the Masters”

April 22, 2021 219374 0 Read More

News | TCTAP 2021 Virtual

How Should Antithrombotic Strategies for CHIP and HBR Patients be tailored

Philip M. Urban, MD (Hopital de la Tour, Switzerland) addressed the prevalence of high bleeding risk (HBR) in patients of percutaneous coronary intervention (PCI) registries across multiple geographical regions at a session held during TCTAP 2021 Virtual.

April 21, 2021 5603 0 Read More

News | TCTAP 2021 Virtual

iFR vs. FFR in Severe AS Patients: Which Is Better, and Is It Valid?

April 21th TCTAP Workshop Session of TCTAP 2021 Virtual

April 21, 2021 7150 0 Read More

News | TCTAP 2021 Virtual

Percutaneous Treatment Considerations for Functional Mitral Regurgitation

Samir R. Kapadia, MD (Cleveland Clinic, Ohio, USA) discussed functional mitral regurgitation (MR) treatment considerations while sharing his experience with MitraClip Implant during a session at TCTAP 2021 Virtual that ran from April 21 to 24.

April 21, 2021 426657 0 Read More